| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 01/02/2004 | EP1373513A2 Streptococcus pneumoniae proteins and nucleic acids |
| 01/02/2004 | EP1373512A1 Fragment of l. lactis plasmid conferring antiphage activity and uses thereof |
| 01/02/2004 | EP1373511A2 Genes and proteins, and their uses |
| 01/02/2004 | EP1373510A2 Mutant allergens |
| 01/02/2004 | EP1373508A2 Human cytokine receptor |
| 01/02/2004 | EP1373506A2 Yeast strain of saccharomyces cerevisiae with functional expression of a glut transporter |
| 01/02/2004 | EP1373505A2 Tri-hybrid melanoma antigen |
| 01/02/2004 | EP1373503A2 Neurotrophic factors |
| 01/02/2004 | EP1373497A2 Method for increasing the production of a secondary metabolite in a microorganism by introducing mutations that confer antibiotic-resistance |
| 01/02/2004 | EP1373496A1 Methods for identifying peptides which modulate a biological process |
| 01/02/2004 | EP1373489A2 Human dual specificity protein phosphatase 7-like protein |
| 01/02/2004 | EP1373485A2 Ikk2 variant, dino gene, lectin-like receptor gene, and proteins encoded thereby |
| 01/02/2004 | EP1373481A1 Methods of screening for introduction of dna into a target cell |
| 01/02/2004 | EP1373480A2 Uncoupled productive and catabolic host cell pathways |
| 01/02/2004 | EP1373476A2 Cytochrome p450s and uses thereof |
| 01/02/2004 | EP1373471A2 Defined culture medium |
| 01/02/2004 | EP1373470A2 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 01/02/2004 | EP1373320A2 Method for preparing and selecting antibodies |
| 01/02/2004 | EP1373318A2 Neutralizing human monoclonal antibodies against hiv-1, their production and uses |
| 01/02/2004 | EP1373317A2 Nuclear hormone receptor ligand binding domains |
| 01/02/2004 | EP1373316A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373315A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373313A2 Proteins and nucleic acids encoding same |
| 01/02/2004 | EP1373312A1 Shellfish protein |
| 01/02/2004 | EP1373306A2 Cytoskeletion-associated proteins |
| 01/02/2004 | EP1373293A1 Steap-related protein |
| 01/02/2004 | EP1373290A1 Pesticidal spinosyn derivatives |
| 01/02/2004 | EP1373285A2 Synthesis and use of glycodendrimer reagents |
| 01/02/2004 | EP1372721A2 Method to screen peptide display libraries using minicell display |
| 01/02/2004 | EP1372718A2 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 01/02/2004 | EP1372640A2 Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of cns disorders and a process for the preparation thereof |
| 01/02/2004 | EP1372418A2 Non-oligomerizing tandem fluorescent proteins |
| 01/02/2004 | EP1372384A2 A novel antagonistic yeast useful in controlling spoilage of agricultural produce, methods of use thereof and compositions containing same |
| 01/02/2004 | EP0506780B2 Stable integration of dna in bacterial genomes |
| 01/01/2004 | US20040003431 Genes coding for flavone synthases |
| 01/01/2004 | US20040003425 Nav2 channel gene-deficient non-human animals |
| 01/01/2004 | US20040003419 Novel taste receptors in Drosophila |
| 01/01/2004 | US20040003417 Animals transgenic for a tetracycline-regulated transcriptional inhibitor |
| 01/01/2004 | US20040002533 Culture product of Streptomyces; lanosterol synthase inhibitor; anticholesterol agents, fungicides |
| 01/01/2004 | US20040002473 Pain modulation; incotinence therapy; central nervous system disorders |
| 01/01/2004 | US20040002468 Methods of treating diabetes and other blood sugar disorders |
| 01/01/2004 | US20040002458 Pharmaceutical compositions and methods using natriuretic peptides |
| 01/01/2004 | US20040002449 METH1 and METH2 polynucleotides and polypeptides |
| 01/01/2004 | US20040002439 Human voltage gated sodium channel beta1A subunit and methods of use |
| 01/01/2004 | US20040002432 Laundering detergent |
| 01/01/2004 | US20040002431 Polypeptide; laundering detergent |
| 01/01/2004 | US20040002156 Selective cloning of homoduplex nucleic acids |
| 01/01/2004 | US20040002155 A strain of host cells that contains a temperature sensitive variant of the gene encoding the endonuclease VII from phage T4; a cloning method that selects for PCR products that are devoid of PCR-generated mutations |
| 01/01/2004 | US20040002154 Methods for preparing libraries of unique tags and related screening methods |
| 01/01/2004 | US20040002149 Control of the ratio of LAP to LIP |
| 01/01/2004 | US20040002147 Improved activity and stability at increased pH/temperature; solid phase synthesis; immunoassays |
| 01/01/2004 | US20040002144 Extrapolating the structure-binding site by replacing, inserting or deleting amino acids; x-ray crystal structure analysis; streptoverticillium mobaraense |
| 01/01/2004 | US20040002143 Introducing a mutation in a promoter sequence of biosynthesizing genes on a chromosome of coryneform bacterium to make it close to a consensus sequence; high yields |
| 01/01/2004 | US20040002142 Glucoamylase variants |
| 01/01/2004 | US20040002141 Methods and compositions for propagating vectors containing toxic cDNAs and ion channel assay systems |
| 01/01/2004 | US20040002139 Methods for making recombinant proteins using apoptosis inhibitors |
| 01/01/2004 | US20040002136 Mutant Chrysosporium strain comprising a nucleic acid sequence encoding a polypeptide; expressing and secreting heterologous proteins |
| 01/01/2004 | US20040002134 Novel nucleic acid sequences encoding human KIAA0768 protein-like and human protein PRO228-like polypeptides |
| 01/01/2004 | US20040002133 Novel compounds |
| 01/01/2004 | US20040002122 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 01/01/2004 | US20040002116 Simple method of cloning, overexpressing and purifying lens protein tau-crystallin |
| 01/01/2004 | US20040002114 Nucleic acids encoding a G-protein coupled receptor involved in islet cell signaling |
| 01/01/2004 | US20040002109 Process for identifying modulators of G-protein-coupled receptors |
| 01/01/2004 | US20040002103 Synthetic ligation reassembly in directed evolution |
| 01/01/2004 | US20040002094 Method to monitor the changes in comprehensive cellular gene expression levels at single length resolution by using a high-density microarray prepared with a comprehensive collection of ORFs (open reading frame) of a genome |
| 01/01/2004 | US20040002092 Hybrid and single chain meganucleases and use thereof |
| 01/01/2004 | US20040002088 Identification and isolation of novel DNA and to the recombinant production of polypeptides having sequence similarity to Glial Cell line-derived Neurotrophic Factor Receptor (GDNFR) |
| 01/01/2004 | US20040002066 36 human secreted proteins |
| 01/01/2004 | US20040002061 Methods of using the signal to transmit and maintain influenza viral and foreign nucleic acid in virus and cells |
| 01/01/2004 | US20040001866 Genetic engineered polypeptides; bactericide |
| 01/01/2004 | US20040001861 Yeast cells cultured in the presence of an alternating electric field having a specific frequency and a specific field strength for a period of time sufficient to increase the capability of the yeast cells to improve the memory of mammals |
| 01/01/2004 | US20040001860 Dietary supplements for enhancing the immune system |
| 01/01/2004 | US20040001859 Anti-aging dietary supplements |
| 01/01/2004 | US20040001858 Dietary supplements beneficial for the liver |
| 01/01/2004 | US20040001857 Dietary supplements for treating hypertension |
| 01/01/2004 | US20040001844 Lewis Y epitope-containing mucin fusion polypeptide vaccines, compositions and methods of use thereof |
| 01/01/2004 | US20040001843 Peptides and DNA encoding the peptides useful for immunizations against Coccidioides spp. infections |
| 01/01/2004 | US20040001832 Childhood obesity; antidiabetic agents; culture product; hybrid nucleic acid |
| 01/01/2004 | US20040001815 Dietary supplements for regulating male hormone |
| 01/01/2004 | US20040001814 Yeast cells that induce immunology |
| 01/01/2004 | US20040001813 Yeast cells that induce immunology |
| 12/31/2003 | WO2004001381A2 Novel raag10 cell surface target and a family of antibodies recognizing that target |
| 12/31/2003 | WO2004001054A2 Flocculation with divalent salt |
| 12/31/2003 | WO2004001048A1 Pharmaceutical composition and method of treatment of human malignancies with arginine deprivation |
| 12/31/2003 | WO2004001047A1 Novel promoter |
| 12/31/2003 | WO2004001041A1 Expression vector, host, fused protein, process for producing fused protein and process for producing protein |
| 12/31/2003 | WO2004001036A1 Compositions and methods for selecting open reading frames |
| 12/31/2003 | WO2004001029A1 Alkaline lipase from vibrio metschnikovii rh530 n-4-8 and nucleotide sequence encoding the same |
| 12/31/2003 | WO2004001022A1 Probiotic propionibacterium jensenii 702 |
| 12/31/2003 | WO2004001021A1 Pasteurisation process for microbial cells and microbial oil |
| 12/31/2003 | WO2004001020A2 Methods and means to promote gut absorption |
| 12/31/2003 | WO2004001003A2 Plastid division and related genes and proteins, and methods of use |
| 12/31/2003 | WO2004000997A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 12/31/2003 | WO2004000422A1 Method of producing organic material and use of the same |
| 12/31/2003 | WO2004000369A2 Method of magnetically manipulating a cell with magnetisable particles |
| 12/31/2003 | WO2004000349A1 Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation |
| 12/31/2003 | WO2004000335A1 Lactic acid bacteria cultures that inhibit food-borne pathogens |
| 12/31/2003 | WO2004000236A2 Modified sodium iodide symporter proteins and genes for imaging and cancer therapy |
| 12/31/2003 | WO2004000096A2 Novel bartonella antigen lysate extracts for use in elisa diagnostic |
| 12/31/2003 | WO2003089015A3 Rapid sterilization and vaccine preparation |